MedTrace Logo

A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius

NCT00548496 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2017-04-12

No results posted yet for this study

Summary

This is a study designed to test the safety and effectiveness of SB-751689 in the treatment of a distal radius fracture in post-menopausal women and men in comparison to placebo to determine if healing time of the fracture can be decreased.

Conditions

  • Fracture Healing

Interventions

DRUG

SB-751689

SB-751689

OTHER

Placebo

Placebo to match

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-20
Primary Completion
2008-11-26
Completion
2008-11-26

Countries

  • Argentina
  • Australia
  • Czechia
  • Hong Kong
  • Netherlands
  • Romania
  • Russia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548496 on ClinicalTrials.gov